PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Clinical Trials

      Recent Articles

      Celcuity Announces Clinical Trial Collaboration with University of Rochester Wilmot Cancer Center and Puma to Study Patients with Breast Cancer Brain Metastases

      Industry News

      Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health

      Look Who’s On the Move!

      Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)

      Regulatory Affairs

      Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis

      Industry News

      Versantis Appoints Leading Hepatologist Prof Dr Katharina Staufer as Chief Medical Officer

      Look Who’s On the Move!

      Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application (NDA) for Zuranolone to the U.S. Food & Drug Administration in the...

      Regulatory Affairs

      AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1

      Industry News

      Humanigen Announces Late-Breaking Presentation at the CHEST Annual Meeting Highlighting C-Reactive Protein as a Biomarker for Identifying Patients Most Likely to Benefit from treatment...

      Industry News

      Enanta Pharmaceuticals Presents New Data for EDP-235, its Lead Oral Protease Inhibitor Designed for the Treatment of COVID-19, at the ISIRV–WHO Virtual Conference 2021

      Industry News

      Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors

      Look Who’s On the Move!

      Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer

      Look Who’s On the Move!

      Better Therapeutics Enrolls First Patient in Real-World Evidence Study with Catalyst Health Network Evaluating BT-001, a Prescription Digital Therapeutic for Type 2 Diabetes

      Industry News

      Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With CFTR Modulators at North American Cystic Fibrosis Conference (NACFC)

      Editor´s Pick

      ImmunityBio Announces Primary Endpoint Met in a Second Indication in Bladder Cancer Trial with 57% Disease-Free Survival in Patients with BCG Unresponsive Papillary Disease

      Industry News

      VisualDx Announces Collaboration with Janssen to Pilot New API and Bring Equitable AI to the Point of Care

      Industry News

      2021 © Copyright - TPMG